2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

TA McDonagh, M Metra, M Adamo… - European heart …, 2021 - academic.oup.com
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …

Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

[HTML][HTML] Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

C Tschöpe, E Ammirati, B Bozkurt… - Nature Reviews …, 2021 - nature.com
Inflammatory cardiomyopathy, characterized by inflammatory cell infiltration into the
myocardium and a high risk of deteriorating cardiac function, has a heterogeneous …

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies

S Frantz, MJ Hundertmark… - European heart …, 2022 - academic.oup.com
Most patients survive acute myocardial infarction (MI). Yet this encouraging development
has certain drawbacks: heart failure (HF) prevalence is increasing and patients affected tend …

Diagnosis and management of myocarditis in children: a scientific statement from the American Heart Association

YM Law, AK Lal, S Chen, D Čiháková, LT Cooper Jr… - Circulation, 2021 - Am Heart Assoc
Myocarditis remains a clinical challenge in pediatrics. Originally, it was recognized at
autopsy before the application of endomyocardial biopsy, which led to a histopathology …

Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis

E Ammirati, L Lupi, M Palazzini, NS Hendren… - Circulation, 2022 - Am Heart Assoc
Background: Acute myocarditis (AM) is thought to be a rare cardiovascular complication of
COVID-19, although minimal data are available beyond case reports. We aim to report the …

Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: The Hamburg City Health Study COVID programme

EL Petersen, A Goßling, G Adam… - European Heart …, 2022 - academic.oup.com
Aims Long-term sequelae may occur after SARS-CoV-2 infection. We comprehensively
assessed organ-specific functions in individuals after mild to moderate SARS-CoV-2 …

[HTML][HTML] Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update

CM Kramer, J Barkhausen, C Bucciarelli-Ducci… - Journal of …, 2020 - Elsevier
This document is an update to the 2013 publication of the Society for Cardiovascular
Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Protocols …

Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the H eart F ailure A ssociation (HFA), the E …

J Čelutkienė, R Pudil… - European journal of …, 2020 - Wiley Online Library
Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection
of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position …